Literature DB >> 31061530

Membrane metalloprotease TRABD2A restricts HIV-1 progeny production in resting CD4+ T cells by degrading viral Gag polyprotein.

Guoxin Liang1,2, Li Zhao3,4, Ying Qiao5, Wenqing Geng3,4, Xiaowei Zhang5, Mei Liu3,4, Jinxiu Dong3,4, Haibo Ding3,4, Hong Sun3,4, Hong Shang6,7,8.   

Abstract

Resting CD4+ T cells are highly resistant to the production of human immunodeficiency virus type 1 (HIV-1). However, the mechanism by which resting CD4+ T cells restrict such production in the late viral replication phase of infection has remained unclear. In this study, we found that the cell membrane metalloprotease TRAB domain-containing protein 2A (TRABD2A) inhibited this production in resting CD4+ T cells by degrading the virion structural precursor polyprotein Gag at the plasma membrane. Depletion or inhibition of metalloprotease activity by TRABD2A profoundly enhanced HIV-1 production in resting CD4+ T cells. TRABD2A expression was much higher in resting CD4+ T cells than in activated CD4+ T cells and was considerably reduced by T cell activation. Moreover, reexpressing TRABD2A reinforced the resistance of activated CD4+ T cells to the production of HIV-1 progeny. Collectively, these results elucidate the molecular mechanism employed by resting CD4+ T cells to potently restrict the assembly and production of HIV-1 progeny.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31061530     DOI: 10.1038/s41590-019-0385-2

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  7 in total

1.  Tiki proteins are glycosylphosphatidylinositol-anchored proteases.

Authors:  Mingyi Li; Jing Zheng; Xi He; Xinjun Zhang
Journal:  FEBS Lett       Date:  2022-02-27       Impact factor: 3.864

2.  Heavy metal protease takes a tiki torch to HIV assembly.

Authors:  Una O'Doherty; Eric O Freed
Journal:  Nat Immunol       Date:  2019-06       Impact factor: 31.250

3.  Next-Generation Sequencing in a Direct Model of HIV Infection Reveals Important Parallels to and Differences from In Vivo Reservoir Dynamics.

Authors:  Marilia Rita Pinzone; Maria Paola Bertuccio; D Jake VanBelzen; Ryan Zurakowski; Una O'Doherty
Journal:  J Virol       Date:  2020-04-16       Impact factor: 6.549

4.  HIV-1 Nef Targets HDAC6 to Assure Viral Production and Virus Infection.

Authors:  Sara Marrero-Hernández; Daniel Márquez-Arce; Romina Cabrera-Rodríguez; Judith Estévez-Herrera; Silvia Pérez-Yanes; Jonathan Barroso-González; Ricardo Madrid; José-David Machado; Julià Blanco; Agustín Valenzuela-Fernández
Journal:  Front Microbiol       Date:  2019-10-30       Impact factor: 5.640

5.  Neuropilin-1, a myeloid cell-specific protein, is an inhibitor of HIV-1 infectivity.

Authors:  Shumei Wang; Li Zhao; Xiaowei Zhang; Jingjing Zhang; Hong Shang; Guoxin Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-11       Impact factor: 12.779

6.  Membrane Protein OTOF Is a Type I Interferon-Induced Entry Inhibitor of HIV-1 in Macrophages.

Authors:  Haibo Ding; Xiaowei Zhang; Zheming Zhu; Shumei Wang; Ying Xiong; Hong Shang; Guoxin Liang
Journal:  mBio       Date:  2022-07-18       Impact factor: 7.786

7.  Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages.

Authors:  Li Zhao; Shumei Wang; Meng Xu; Yang He; Xiaowei Zhang; Ying Xiong; Hong Sun; Haibo Ding; Wenqing Geng; Hong Shang; Guoxin Liang
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.